Hemoglobin subunit gamma 1 and gamma 2 gene promoter

The hemoglobin subunit gamma 1 and gamma 2 gene promoters are regulatory DNA elements located upstream of the HBG1 and HBG2 genes, which code for the gamma subunits of fetal hemoglobin (HbF). These promoters control the developmental expression of gamma-globin in the fetal liver, spleen, and bone marrow and are essential in the switch from fetal to adult forms of hemoglobin after birth. Persistence or reactivation of these promoters in adulthood can compensate for mutated or insufficient beta-globin production in hemoglobinopathies such as beta-thalassemia and sickle cell disease. The promoters are target sites for certain transcription factors (e.g., TEA domain transcription factor 4) that modulate gamma-globin expression[1][2][3]. The promoters are not proteins or classical drug targets but are critical in gene therapy and pharmacological approaches aimed at reactivating fetal hemoglobin in adults. They are not considered therapeutic targets in the sense of receptors, enzymes, or proteins but have significant clinical importance for regulated gene expression in diseases affecting hemoglobin[1][2][3]. Information about drugs or direct modulators is limited, as most therapeutic interventions target proteins regulating these promoters or employ genome editing technologies.

Other names

HBG1 and HBG2 promotersGamma-globin gene promotersFetal hemoglobin gene promoters